For example, the overexpression of miR-205-5p was detected in patients with non-small cell lung cancer compared with controls [32], and miR-205-5p was significantly downregulated in estrogen receptor-positive breast cancer by targeting NFIB [33]. This evidence concerns the gene ESR1 and breast carcinoma.